Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA 403 Forbidden error now appears on the page, replacing the previous study record content with an error screen. This prevents users from viewing the study details, locations, and related information on the page.SummaryDifference20%

- Check55 days agoChange DetectedThe page adds an NIH grant/contract reference from 2018 and updates the revision notice to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, signaling a minor software version update to the site's backend or UI.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page's metadata. No substantive study content appears to be altered.SummaryDifference0.0%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.